Citalopram as adjunctive therapy in bipolar depression Academic Article uri icon

Overview

MeSH Major

  • Antimanic Agents
  • Bipolar Disorder
  • Citalopram

abstract

  • The high response rate, the high rate of sustained remission, and the low rate of adverse events strongly support the use of citalopram as a treatment for bipolar I or II depression. These findings should stimulate a controlled double-blind trial to demonstrate even more clearly the usefulness of this drug in the therapeutic regimen for bipolar disorder.

publication date

  • January 2001

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.4088/JCP.v62n1212

PubMed ID

  • 11780881

Additional Document Info

start page

  • 985

end page

  • 90

volume

  • 62

number

  • 12